1. Home
  2. AGRZ vs IMNN Comparison

AGRZ vs IMNN Comparison

Compare AGRZ & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGRZ

Agroz Inc. Ordinary Shares

N/A

Current Price

$0.19

Market Cap

6.9M

ML Signal

N/A

Logo Imunon Inc.

IMNN

Imunon Inc.

N/A

Current Price

$1.38

Market Cap

7.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AGRZ
IMNN
Founded
2020
1982
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
7.9M
IPO Year
2024
2000

Fundamental Metrics

Financial Performance
Metric
AGRZ
IMNN
Price
$0.19
$1.38
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
★ 5.9M
127.2K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.15
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$1.30
52 Week High
$7.20
$5.55

Technical Indicators

Market Signals
Indicator
AGRZ
IMNN
Relative Strength Index (RSI) 36.21 44.10
Support Level $0.19 N/A
Resistance Level $0.43 $1.75
Average True Range (ATR) 0.04 0.13
MACD -0.00 0.00
Stochastic Oscillator 0.76 28.89

Price Performance

Historical Comparison
AGRZ
IMNN

About AGRZ Agroz Inc. Ordinary Shares

Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Share on Social Networks: